JP2024515934A5 - - Google Patents

Info

Publication number
JP2024515934A5
JP2024515934A5 JP2023555736A JP2023555736A JP2024515934A5 JP 2024515934 A5 JP2024515934 A5 JP 2024515934A5 JP 2023555736 A JP2023555736 A JP 2023555736A JP 2023555736 A JP2023555736 A JP 2023555736A JP 2024515934 A5 JP2024515934 A5 JP 2024515934A5
Authority
JP
Japan
Application number
JP2023555736A
Other languages
Japanese (ja)
Other versions
JPWO2022211508A5 (https=
JP2024515934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2022/004552 external-priority patent/WO2022211508A1/ko
Publication of JP2024515934A publication Critical patent/JP2024515934A/ja
Publication of JPWO2022211508A5 publication Critical patent/JPWO2022211508A5/ja
Publication of JP2024515934A5 publication Critical patent/JP2024515934A5/ja
Pending legal-status Critical Current

Links

JP2023555736A 2021-03-30 2022-03-30 ヒトcldn18.2に対する抗体を含む抗体-薬物コンジュゲートおよびその使用 Pending JP2024515934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2021-0041447 2021-03-30
KR20210041447 2021-03-30
PCT/KR2022/004552 WO2022211508A1 (ko) 2021-03-30 2022-03-30 인간 cldn18.2에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도

Publications (3)

Publication Number Publication Date
JP2024515934A JP2024515934A (ja) 2024-04-11
JPWO2022211508A5 JPWO2022211508A5 (https=) 2026-02-25
JP2024515934A5 true JP2024515934A5 (https=) 2026-02-25

Family

ID=83459705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555736A Pending JP2024515934A (ja) 2021-03-30 2022-03-30 ヒトcldn18.2に対する抗体を含む抗体-薬物コンジュゲートおよびその使用

Country Status (11)

Country Link
US (1) US20240131178A1 (https=)
EP (1) EP4321180A1 (https=)
JP (1) JP2024515934A (https=)
KR (1) KR20220136267A (https=)
CN (1) CN117279663A (https=)
AU (1) AU2022250810A1 (https=)
BR (1) BR112023020093A2 (https=)
CA (1) CA3213985A1 (https=)
IL (1) IL307301A (https=)
MX (1) MX2023011507A (https=)
WO (1) WO2022211508A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019011655A (es) 2017-03-29 2019-12-19 Legochem Biosciences Inc Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este.
US20250242043A1 (en) * 2022-04-06 2025-07-31 Ligachem Biosciences Inc. Antibody-drug conjugate comprising antibody against human trop2 and use thereof
KR20240101987A (ko) 2022-12-23 2024-07-03 주식회사 와이바이오로직스 클라우딘-18.2에 특이적으로 결합하는 단클론항체 및 이의 용도
EP4642489A1 (en) * 2022-12-26 2025-11-05 Full-Life Technologies HK Limited Conjugate and uses thereof
JP2026510495A (ja) * 2023-03-10 2026-04-07 リガケム バイオサイエンシズ, インク. ヒトl1camに対する抗体を含む抗体-薬物コンジュゲートおよびその使用
AR132368A1 (es) 2023-04-18 2025-06-18 Astrazeneca Ab Conjugados que comprenden enlazadores escindibles
WO2025032556A1 (en) * 2023-08-10 2025-02-13 Beigene Switzerland Gmbh Bioactive conjugates, preparation method and use thereof
WO2025032555A1 (en) * 2023-08-10 2025-02-13 Beigene Switzerland Gmbh Bioactive conjugates, preparation method and use thereof
WO2025078881A2 (en) * 2023-10-13 2025-04-17 Ligachem Biosciences Inc. Anti-claudin 18.2 antibody drug conjugates comprising topoisomerase i inhibitor and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880935A (en) 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
IL106992A (en) 1988-02-11 1994-06-24 Bristol Myers Squibb Co Acylhydrazone derivatives of anthracycline and methods for their preparation
US5622929A (en) 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
ATE234635T1 (de) 1995-12-22 2003-04-15 Bristol Myers Squibb Co Verzweigte hydrazongruppen enthaltende kuppler
HUE045348T2 (hu) 2011-05-08 2019-12-30 Legochem Biosciences Inc Fehérje-hatóanyag konjugátumok és eljárás elõállításukra
KR101628872B1 (ko) 2014-05-28 2016-06-09 주식회사 레고켐 바이오사이언스 자가-희생 기를 포함하는 화합물
HRP20240795T1 (hr) 2015-11-25 2024-09-13 Ligachem Biosciences Inc. Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima
KR102847350B1 (ko) 2015-11-25 2025-08-19 주식회사 리가켐바이오사이언스 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법
MX2019011655A (es) * 2017-03-29 2019-12-19 Legochem Biosciences Inc Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este.
CN111867630B (zh) * 2018-06-17 2023-10-13 上海健信生物医药科技有限公司 靶向cldn18.2的抗体、双特异性抗体、adc和car及其应用

Similar Documents

Publication Publication Date Title
JP2025511705A5 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13161U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13176U (https=)
BY13175U (https=)